Global Health
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Gain critical intelligence on global health trends, pharmaceutical market dynamics, and regulatory shifts impacting drug development and access worldwide.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Global Health hub for NMPA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Helus Pharma to Participate in the Jefferies Global Healthcare Conference: Strategic Implications for Analysts and BD Teams
GHIT Fund Invests $8.5 Million in Malaria and Neglected Tropical Disease Drug Development with GSK, Eisai Partners
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.